Data_Sheet_7_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Data_Sheet_4_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Data_Sheet_8_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Data_Sheet_1_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Data_Sheet_6_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

DataSheet1_Mass Spectrometry-Based Targeted Serum Monomethylated Ribonucleosides Profiling for Early Detection of Breast Cancer.PDF by Zhihao Fang (9857225)

“…We discovered that the levels of Gm, m¹G, Cm, Um and m⁵U in serum were all significantly decreased in breast cancer patients whereas m⁶A was increased. …”

In vivo assessment of combination of YM155 and sorafenib using a patient-derived RCC xenograft model in SCID mice. by Mei Yi Sim (4067998)

“…(A) The mean tumour volume of vehicle-, YM155-, sorafenib- and (YM155-sorafenib)- treated mice at the given time-points showed a decrease in the rate of tumour growth when compared to the vehicle control. …”

Multi-way sensitivity analysis on regional access to care and linkage to care with POC-CD4 compared to LAB-CD4. by Emily P. Hyle (512613)

“…<p>Projected decrease in 5-y mortality and ICERs with use of POC-CD4 compared to LAB-CD4 in four settings that represent a range of access to care (decreasing access to care from left to right) and with different probabilities of linkage with POC-CD4 (increasing up the vertical axis). …”

Effects of HDAC8 inhibition on MPNST cell cycle and apoptosis. by Gonzalo Lopez (22820)

“…<p><b>A.</b> PI staining/FACS analyses showing the effect of HDACis (PCI2 0.5μM/48h, PCI3/4 5μM/48h) on human and murine-derived MPNST cell cycle progression. …”

Variation in actuarial senescence does not reflect life span variation across mammals by Guillaume Péron (655312)

“…Actuarial senescence only accounted for 35%–50% of the variance in life span across species, depending on the body mass category. We computed the sensitivity and elasticity of life span to five parameters that represent the three stages of the age-specific mortality curve—namely, the duration of the juvenile stage, the mean juvenile mortality, the prime-age (i.e., minimum) adult mortality, the age at the onset of actuarial senescence, and the rate of actuarial senescence. …”

Redox status of rat cortical neurons. by Inmaculada Posadas (218859)

“…V stands for vehicle (DMSO 1‰)-treated cells. Data represent the mean ± SEM of 9 independent experiments. ***, p<i><</i>0.001 as compared to vehicle-treated cells (V); ^###, p<i><</i>0.001 compared to AAP 2 mM (A2). …”

PhoH2 acts on <i>sigF</i> RNA. by Emma S. V. Andrews (5706821)

“…<p>(A) <i>sigF</i>, (B) <i>rsbW-sigF</i> and (C) <i>MSMEG_0467</i> RNA transcripts were assayed with PhoH2 over time. …”

Data_Sheet_1_The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (C... by Rohan Ameratunga (6988931)

“…Over the course of 12 years, 120 patients were enrolled in the NZ hypogammaglobulinemia study (NZHS) including 59 who were asymptomatic.</p><p>Results: Five patients with profound primary hypogammaglobulinemia (IgG < 3 g/l), who were not on regular SCIG/IVIG have remained well for a mean duration of 139 months. …”

Effect of Wendler glottoplasty on voice and quality of life of transgender women by Mateus Morais Aires (14644001)

“…There was a mean increase of 47.9 ± 46.6 Hz (p = 0.023) in sustained/e/F0 and a mean increase of 24.6 ± 27.5 Hz (p = 0.029) in speaking F0 after glottoplasty. …”

Strain-degradation analysis of tunnel structures based on twin-shear unified strength criterion by Yongtao Bai (6483680)

Thermal Quenching and Dose Studies of X‑ray Luminescence in Single Crystals of Halide Perovskites by Aozhen Xie (1800532)

“…This quenching is strongly affected by the decrease of the thermal activation energy Δ<i>E</i>_q from 53 ± 3 to 6 ± 1 meV. …”

Text S1 - Down-Regulating Sphingolipid Synthesis Increases Yeast Lifespan by Xinhe Huang (185390)

“…Figure S2: Myriocin treatment decreases cell size. DBY746 cells were grown with and without myriocin (Myr) as in a CLS assay using SDC medium (pH 4.5, 3X iron). …”

Signal properties measured on leaves with discontinuous substrate (Test 2). by Anna Eriksson (176834)

“…<p>Mean (±SE) values of maximum substrate vibration velocity (mm/s) (A, logarithmic scale) and frequency (Hz) (B) of pulses from MCS (Male calling signal) are shown. …”

Experimental Investigation of Isobaric specific heat capacity (Cp) of 9-ethylcarbazole in liquid and solid state by Ahsan Ali (6478244)

“…<div><p>ABSTRACT Liquid organic hydrides, e.g. 9-ethylcarbazole, are potentially interesting hydrogen storage materials because of their reversible hydrogen sorption properties. …”

Impaired survival signalling in CD PMN does not affect intermediate and end-stage apoptosis. by Rajesh Somasundaram (499673)

“…Representative experiment is shown. (D) Significantly decreased levels of activated STAT3 were observed in CD patients compared to HC (mean±SEM, *p=0.04, n=5). …”